185 related articles for article (PubMed ID: 34713218)
61. Protocol for Construction of a Tunable CRISPR Interference (tCRISPRi) Strain for
Li XT; Sou C; Jun S
Bio Protoc; 2017 Oct; 7(19):. PubMed ID: 29082292
[TBL] [Abstract][Full Text] [Related]
62. Rapid Multiplexed Flow Cytometric Validation of CRISPRi sgRNAs in Tissue Culture.
Chorba JS; Xia VQ; Smith GA; Padmanabhan A
Bio Protoc; 2023 Jan; 13(2):. PubMed ID: 36789164
[TBL] [Abstract][Full Text] [Related]
63. Rewiring capsule production by CRISPRi-based genetic oscillators demonstrates a functional role of phenotypic variation in pneumococcal-host interactions.
Rueff AS; van Raaphorst R; Aggarwal S; Santos-Moreno J; Laloux G; Schaerli Y; Weiser JN; Veening JW
bioRxiv; 2023 Jun; ():. PubMed ID: 37398107
[TBL] [Abstract][Full Text] [Related]
64. dCas9-3xSRDX-mediated transcriptional repression in sugarcane.
Hooghvorst I; Altpeter F
Plant Cell Rep; 2023 Nov; 42(11):1837-1840. PubMed ID: 37667014
[TBL] [Abstract][Full Text] [Related]
65. CDKL5 deficiency disorder: a pathophysiology of neural maintenance.
Kind PC; Bird A
J Clin Invest; 2021 Nov; 131(21):. PubMed ID: 34720088
[TBL] [Abstract][Full Text] [Related]
66. Neuronal Cell-type Engineering by Transcriptional Activation.
Liu S; Striebel J; Pasquini G; Ng AHM; Khoshakhlagh P; Church GM; Busskamp V
Front Genome Ed; 2021; 3():715697. PubMed ID: 34713262
[TBL] [Abstract][Full Text] [Related]
67. Genome Editing in iPSC-Based Neural Systems: From Disease Models to Future Therapeutic Strategies.
McTague A; Rossignoli G; Ferrini A; Barral S; Kurian MA
Front Genome Ed; 2021; 3():630600. PubMed ID: 34713254
[TBL] [Abstract][Full Text] [Related]
68. Methodologies and Challenges for CRISPR/Cas9 Mediated Genome Editing of the Mammalian Brain.
Nishizono H; Yasuda R; Laviv T
Front Genome Ed; 2020; 2():602970. PubMed ID: 34713226
[TBL] [Abstract][Full Text] [Related]
69. Area postrema neurons mediate interleukin-6 function in cancer cachexia.
Sun Q; van de Lisdonk D; Ferrer M; Gegenhuber B; Wu M; Park Y; Tuveson DA; Tollkuhn J; Janowitz T; Li B
Nat Commun; 2024 Jun; 15(1):4682. PubMed ID: 38824130
[TBL] [Abstract][Full Text] [Related]
70. A synthetic biology approach for the treatment of pollutants with microalgae.
Webster LJ; Villa-Gomez D; Brown R; Clarke W; Schenk PM
Front Bioeng Biotechnol; 2024; 12():1379301. PubMed ID: 38646010
[TBL] [Abstract][Full Text] [Related]
71. Monoubiquitination of histone H2B is a crucial regulator of the transcriptome during memory formation.
Navabpour S; Farrell K; Kincaid SE; Omar N; Musaus M; Lin Y; Xie H; Jarome TJ
Learn Mem; 2024 Mar; 31(3):. PubMed ID: 38580378
[TBL] [Abstract][Full Text] [Related]
72. Distinct roles of Bdnf I and Bdnf IV transcript variant expression in hippocampal neurons.
Bach SV; Bauman AJ; Hosein D; Tuscher JJ; Ianov L; Greathouse KM; Henderson BW; Herskowitz JH; Martinowich K; Day JJ
Hippocampus; 2024 May; 34(5):218-229. PubMed ID: 38362938
[TBL] [Abstract][Full Text] [Related]
73. Current Status and Future Strategies for Advancing Functional Circuit Mapping
Berndt A; Cai D; Cohen A; Juarez B; Iglesias JT; Xiong H; Qin Z; Tian L; Slesinger PA
J Neurosci; 2023 Nov; 43(45):7587-7598. PubMed ID: 37940594
[TBL] [Abstract][Full Text] [Related]
74. Temporally specific gene expression and chromatin remodeling programs regulate a conserved
Phillips RA; Wan E; Tuscher JJ; Reid D; Drake OR; Ianov L; Day JJ
Elife; 2023 Nov; 12():. PubMed ID: 37938195
[TBL] [Abstract][Full Text] [Related]
75. Current Approaches to Epigenetic Therapy.
Griazeva ED; Fedoseeva DM; Radion EI; Ershov PV; Meshkov IO; Semyanihina AV; Makarova AS; Makarov VV; Yudin VS; Keskinov AA; Kraevoy SA
Epigenomes; 2023 Sep; 7(4):. PubMed ID: 37873808
[TBL] [Abstract][Full Text] [Related]
76. Neuronal and astrocytic protein degradation are critical for fear memory formation.
Farrell K; McFadden T; Jarome TJ
Learn Mem; 2023 Mar; 30(3):70-73. PubMed ID: 36921984
[TBL] [Abstract][Full Text] [Related]
77. Inducible CRISPR Epigenome Systems Mimic Cocaine Induced Bidirectional Regulation of Nab2 and Egr3.
Choi EY; Franco D; Stapf CA; Gordin M; Chow A; Cover KK; Chandra R; Lobo MK
J Neurosci; 2023 Mar; 43(13):2242-2259. PubMed ID: 36849419
[TBL] [Abstract][Full Text] [Related]
78. CRISPR/Cas-Based Approaches to Study Schizophrenia and Other Neurodevelopmental Disorders.
Kurishev AO; Karpov DS; Nadolinskaia NI; Goncharenko AV; Golimbet VE
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613684
[TBL] [Abstract][Full Text] [Related]
79. Novel methods for the generation of genetically engineered animal models.
Cassidy A; Onal M; Pelletier S
Bone; 2023 Feb; 167():116612. PubMed ID: 36379415
[TBL] [Abstract][Full Text] [Related]
80. Quantitative trait locus (xQTL) approaches identify risk genes and drug targets from human non-coding genomes.
Bykova M; Hou Y; Eng C; Cheng F
Hum Mol Genet; 2022 Oct; 31(R1):R105-R113. PubMed ID: 36018824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
